Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03428373
Title ASA vs. Rivaroxaban in Newly Diagnosed or Relapsed and Refractory Multiple Myeloma Patients Treated With Len-Dex Combination Therapy. (RithMM)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Lawson Health Research Institute

multiple myeloma


Dexamethasone + Lenalidomide + Rivaroxaban

Aspirin + Dexamethasone + Lenalidomide

Age Groups: senior | adult
Covered Countries CAN

No variant requirements are available.